Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor.

When survival data from both Hep3B and SNU-449 models were combined ( Figure 5 H), the Mantel-Cox log rank test generated a highly significant difference between LV-treated and control groups (p = 0.0018).

also in 132,142 other papers